In vivo, NSD2 inhibition reduced tumor growth in immunocompetent mice and increased frequency of CD8+ T cells [47], whereas no tumor suppression was observed in immunodeficient mice, underscoring the importance of a functional immune system [47]. This evidence concerns the gene CD8A and neoplasm.